Industry Projects | Projects by Region | Projects by Category | Archived Projects | Project Gallery
 

Naproxcinod (HCT 3012) - COX-Inhibiting Nitric Oxide-Donator



NSAIDs are the cornerstone of analgesia, providing relief from everyday pains such as headache, toothache, muscular aches, mild joint pain and period pain. (Source: ABPI)


Back to Project Details



Related Projects

Xolair - Biological Therapy
The product of a joint development programme between Tanox, Genentech...

Acomplia (Rimonabant) - Investigational Agent for the Management of Obesity
Developed by Sanofi-Aventis, Acomplia (rimonabant) is a selective...

Tarceva - Small Molecule
Tarceva (erlotinib) is an oral anti-cancer drug developed by...

Lyrica (Pregabalin) - New Gabapentinoid with Wide
Developed by Pfizer, pregabalin, marketed under the brand name Lyrica, is...

Sativex - Investigational Cannabis-Based treatment for Pain and Multiple Sclerosis
Developed by GW Pharmaceuticals, Sativex is a whole plant medicinal...

See all projects


Twitter Twitter    Facebook Facebook   
Contact us
Advertise with us
Terms and conditions
Privacy
Links
Newsletter sign up
Online magazine sign up

drugdevelopment-technology.com is a product of Net Resources International. Copyright 2012 Net Resources International, a trading division of SPG Media Limited.